Kinome expression profiling to target new therapeutic avenues in multiple myeloma

Multiple myeloma (MM) account for approximately 10% of hematological malignancies and is the second most common hematological disorder. Kinases inhibitors are widely used and their efficiency for the treatment of cancers has been demonstrated. Here, in order to identify kinases of potential therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: de Boussac, Hugues, Bruyer, Angélique, Jourdan, Michel, Maes, Anke, Robert, Nicolas, Gourzones, Claire, Vincent, Laure, Seckinger, Anja, Cartron, Guillaume, Hose, Dirk, De Bruyne, Elke, Kassambara, Alboukadel, Pasero, Philippe, Moreaux, Jérôme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049359/
https://www.ncbi.nlm.nih.gov/pubmed/31289205
http://dx.doi.org/10.3324/haematol.2018.208306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049359/
https://www.ncbi.nlm.nih.gov/pubmed/31289205
http://dx.doi.org/10.3324/haematol.2018.208306

Ejemplares similares